Wellington Management Group LLP Increases Holdings in Qiagen N.V. $QGEN

Key Points

• Wellington Management Group LLP has increased its holdings in Qiagen N.V. by 12.2%, owning approximately 10.99% of the company, with a value of about $972 million.
• Qiagen's stock received mixed ratings from analysts, with some downgrading it to a "buy" rating and others issuing hold ratings, reflecting a current average target price of $49.69.
• In the last reported quarter, Qiagen posted a $0.60 earnings per share and revenue of approximately $533.54 million, indicating a year-over-year revenue growth of 7.7%.

Wellington Management Group LLP grew its holdings in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 12.2% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 24,438,441 shares of the company's stock after purchasing an additional 2,656,136 shares during the quarter. Wellington Management Group LLP owned approximately 10.99% of Qiagen worth $972,191,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. LPL Financial LLC increased its holdings in Qiagen by 2.6% in the 4th quarter. LPL Financial LLC now owns 17,240 shares of the company's stock worth $768,000 after acquiring an additional 432 shares during the last quarter. Wells Fargo & Company MN increased its holdings in Qiagen by 31.8% in the 4th quarter. Wells Fargo & Company MN now owns 66,779 shares of the company's stock worth $2,974,000 after acquiring an additional 16,106 shares during the last quarter. Bridgewater Associates LP purchased a new stake in Qiagen in the 4th quarter worth about $259,000. Commerce Bank increased its holdings in Qiagen by 20.4% in the 4th quarter. Commerce Bank now owns 5,931 shares of the company's stock worth $264,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Forum Financial Management LP purchased a new stake in Qiagen in the 4th quarter worth about $221,000. 70.00% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Wall Street Zen lowered Qiagen from a "strong-buy" rating to a "buy" rating in a report on Monday, August 11th. Cowen reissued a "hold" rating on shares of Qiagen in a report on Thursday, August 7th. UBS Group lifted their price objective on Qiagen from $48.00 to $50.00 and gave the stock a "neutral" rating in a report on Thursday, August 7th. Barclays assumed coverage on Qiagen in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $55.00 target price for the company. Finally, Bank of America raised their target price on Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a research note on Thursday, June 26th. Eight research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $49.69.

Qiagen Stock Performance

Shares of QGEN opened at $48.66 on Tuesday. The company has a market cap of $10.82 billion, a PE ratio of 28.75, a price-to-earnings-growth ratio of 2.59 and a beta of 0.64. The company has a current ratio of 1.61, a quick ratio of 1.35 and a debt-to-equity ratio of 0.25. The stock has a 50-day moving average price of $48.42 and a 200-day moving average price of $43.74. Qiagen N.V. has a 12-month low of $37.63 and a 12-month high of $51.88.

Qiagen (NYSE:QGEN - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.60 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.60. The firm had revenue of $533.54 million during the quarter, compared to the consensus estimate of $523.97 million. Qiagen had a return on equity of 14.77% and a net margin of 18.30%. The company's revenue for the quarter was up 7.7% on a year-over-year basis. During the same quarter last year, the company posted $0.55 EPS. As a group, equities analysts forecast that Qiagen N.V. will post 2.26 earnings per share for the current fiscal year.

Qiagen Dividend Announcement

The firm also recently declared a dividend, which was paid on Thursday, July 10th. Stockholders of record on Thursday, July 3rd were given a dividend of $0.25 per share. This represents a dividend yield of 52.0%. The ex-dividend date was Wednesday, July 2nd. Qiagen's dividend payout ratio (DPR) is 14.79%.

About Qiagen

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.